Product NDC: | 55111-291 |
Proprietary Name: | Sumatriptan Succinate |
Non Proprietary Name: | Sumatriptan Succinate |
Active Ingredient(s): | 25 mg/1 & nbsp; Sumatriptan Succinate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55111-291 |
Labeler Name: | Dr. Reddy's Laboratories Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076847 |
Marketing Category: | ANDA |
Start Marketing Date: | 20091117 |
Package NDC: | 55111-291-05 |
Package Description: | 500 TABLET in 1 BOTTLE (55111-291-05) |
NDC Code | 55111-291-05 |
Proprietary Name | Sumatriptan Succinate |
Package Description | 500 TABLET in 1 BOTTLE (55111-291-05) |
Product NDC | 55111-291 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Sumatriptan Succinate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20091117 |
Marketing Category Name | ANDA |
Labeler Name | Dr. Reddy's Laboratories Limited |
Substance Name | SUMATRIPTAN SUCCINATE |
Strength Number | 25 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |